Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Yazan Al-Khalila, MD

Dr Al-Khalila is a first-year psychiatry resident at Creighton University in Omaha, Nebraska.

Articles by Yazan Al-Khalila, MD

tDCS

Home-Based tDCS for Depression: Expanding Access to Neuromodulation Treatment

ByGrethel Perez Meek, DO,Yazan Al-Khalila, MD,Clara Bing-Bauer, MD,Albert Dickan, MD,Haley Schuster, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

August 17th 2026

Remote, home-based tDCS shows modest symptom relief and higher remission in major depression, with generally good safety but burn risks to watch.

brain pills

Evaluating the Efficacy of CBT Plus Psychopharmacology vs Psychopharmacology Alone in the Treatment of Adult ADHD

ByYazan Al-Khalila, MD,Hesham Essa, MD,Haley Schuster, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

September 17th 2025

Combining cognitive behavioral therapy with medication enhances ADHD treatment in adults, showing significant benefits within 3 months.

Latest Updated Articles

Evaluating the Efficacy of CBT Plus Psychopharmacology vs Psychopharmacology Alone in the Treatment of Adult ADHD
September 17th 2025

Trending on Psychiatric Times

Neuropsychiatry in the News: Wearable Technology for Parkinson Disease, Ecopipam for Tourette Syndrome

Psyched Perspectives: ADHD in Underrecognized Populations, With Paige Walton, MD

Let’s Talk About Drug Testing

FDA Feedback Paves Way for New IND Filing for PT00114 in Generalized Anxiety Disorder

Update on Varenicline for Smoking Cessation in Patients With Bipolar Disorder